Mice with prostate-targeted PTEN knockout show increased PI3K/AKT activation and developed prostate cancer [185].The activation of PI3K pathway could also occur due to overexpression or activating mutations of AKT or PI3K [11]. The gene discussed is AKT1; the disease is prostate carcinoma.